Search Results 1171-1180 of 13323 for monoclonal antibody

1. Controlled Clinical Study of Dupilumab in Patients With Nasal Polyps

   Any experimental monoclonal antibody (mAB) within 5 half-lives or within 6 months before V1 if the half-life is unknown. Anti-immunoglobulin E therapy ...

2. Ublituximab In Autoantibody Positive Immune Mediated Necrotizing Myopathy - Mayo Clinic

   About this study. This is a multi-center, Phase 2 trial of ublituximab as first-line combination therapy in early, active autoantibody positive ...

3. An Open-label Study To Assess The Anti-Tumor Activity And Safety Of REGN1979, An Anti-CD20 X Anti-CD3 Bispecific Antibody, In Patients With Relapsed Or Refractory B-cell Non-Hodgkin Lymphoma - Mayo Clinic

   An Open-label Study To Assess The Anti-Tumor Activity And Safety Of REGN1979, An Anti-CD20 X Anti-CD3 Bispecific Antibody, In Patients With Relapsed Or ...

4. Estradiol In Treating Patients With ER Beta Positive, Triple Negative Locally Advanced Or Metastatic Breast Cancer - Mayo Clinic

   ≤2 prior chemotherapy regimens for treatment of metastatic breast cancer Note: Prior use of monoclonal antibodies targeting PD1, PDL1 is allowed. ECOG ...

5. Hepatocellular Carcinoma (HCC) Clinical Trials - Mayo Clinic Research

   The purpose of this study is to assess the efficacy and safety of tiragolumab, an anti-TIGIT monoclonal antibody, when administered in combination with ...

6. Medical Research & Education - Mayo Clinic News Network

   Antibody-drug conjugates are targeted cancer therapies. They deliver potent drugs directly into cancer cells while minimizing harm to healthy tissue. These ...

7. Novel SEQUEnced Immunotherapy With Anti-angiogenesis And Chemotherapy In Advanced GastroesophageaL Adenocarcinoma (SEQUEL) - Mayo Clinic

   ... monoclonal antibody or hypersensitivity to pembrolizumab or any of its excipients. - Has had a prior anti-cancer monoclonal antibody (mAb) within 4 weeks ...

8. Gary A. Croghan, M.D., Ph.D. - Doctors and Medical Staff - Mayo Clinic

   1983. PhD - General Experimental Pathology Dissertation: An Epithelial and Tumor-Associated Antigen Recognized by Monoclonal Antibody F36/22State University of ...

9. Study To Evaluate Efficacy And Safety Of Mepolizumab For Frequently Exacerbating Chronic Obstructive Pulmonary Disease (COPD) Patients - Mayo Clinic

   Monoclonal antibodies: Subjects who have received any monoclonal antibody within 5 half-lives of Visit 1. Investigational medications: Subjects who have ...

10. Tebentafusp Regimen Versus Investigator's Choice In Previously Treated Advanced Melanoma (TEBE-AM) - Mayo Clinic

    * previous severe hypersensitivity reaction to treatment with another monoclonal antibody (mAb) * active autoimmune disease requiring immunosuppressive ...